BA
The Boeing Company
BA has a slight edge over HLMN overall, supported by stronger modeled upside and stronger fundamentals.
HLMN
Hillman Solutions Corp.
HLMN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
HLMN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Under pressure |
HLMN's revenue and cash flow are currently healthy, and its profitability is stable, but its balance sheet is under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over HLMN in the historical PE scenario, which offers more potential upside but is not a forecast.
HLMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $7.90 | — |
| Cheap | 42x | $5.03 | -36% |
| Current | 66x | $7.90 | — |
| Fair | 78x | $9.31 | +18% |
| Expensive | 337x | $40.48 | +412% |
Historical ranges are pointers, not guarantees.
HLMN's PE is in its fair range at 66x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over HLMN on the outlook, with more favorable profitability expectations.
HLMN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HLMN, with profitability holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
HLMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.63 | +422% |
| Q3 2026 | $0.12 | -40% |
| Q2 2026 | $0.21 | +75% |
| Q1 2026 | $0.18 | +80% |
| Q4 2025 | $0.20 | +122% |
| Q3 2025 | $0.20 | +400% |
| Q2 2025 | $0.12 | +300% |
| Q1 2025 | $0.10 | +$0.11 |
| Q4 2024 | $0.09 | +$0.14 |
HLMN has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
HLMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $457.5M | +7.7% |
| Q2 2026 | $442.3M | +9.8% |
| Q1 2026 | $370.1M | +3% |
| Q4 2025 | $365.1M | +4.5% |
| Q3 2025 | $424.9M | +8% |
| Q2 2025 | $402.8M | +6.2% |
| Q1 2025 | $359.3M | +2.6% |
| Q4 2024 | $349.6M | +0.5% |
HLMN's revenue has grown year over year for eight quarters in a row: $457M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | -2.5 points |
| Q2 2026 | 9.3% | +0.2 points |
| Q1 2026 | 1.9% | -2.2 points |
| Q4 2025 | 4.6% | +0.6 points |
| Q3 2025 | 11% | +4 points |
| Q2 2025 | 9% | +0.7 points |
| Q1 2025 | 4.2% | -0.5 points |
| Q4 2024 | 4% | +2.8 points |
HLMN has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over HLMN on cash flow, with more consistent year-over-year improvement.
HLMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $51.1M | +464% |
| Q2 2026 | $70.2M | +125% |
| Q1 2026 | -$34.3M | -$13M |
| Q4 2025 | $16.1M | -27% |
| Q3 2025 | $9.1M | -77% |
| Q2 2025 | $31.2M | -27% |
| Q1 2025 | -$21.3M | -$15.2M |
| Q4 2024 | $22.1M | -58% |
HLMN still generates free cash flow, though less than at its 2026 peak: $103M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HLMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -833K shares |
| 1 year | -1.9% | -3.8M shares |
| 3 years | -0.3% | -517K shares |
| 5 years | +1056% | +179M shares |
HLMN has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5M |
| Q2 2026 | $13.3M |
| Q1 2026 | $10.1M |
| Q4 2025 | $9.3M |
| Q2 2020 | — |
| Q1 2020 | — |
HLMN spent $38M buying back its own shares over the past year.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over HLMN on leverage, with a lower net debt burden relative to earnings.
HLMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.7x | Elevated |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.0x | Elevated |
HLMN's net debt is about 3.7 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
HLMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 48.0 | Neutral |
HLMN's weekly RSI is 51 (neutral) and its Stochastic is 48 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over HLMN on valuation relative to its sector.
HLMN PE vs Industrials Sector
| Metric | HLMN | Sector median | Relative |
|---|---|---|---|
| PE | 66x | 24x | 173% above |
| PE % | 39 | 56 | 17 pts below |
HLMN is trading at 66x earnings, a 173% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
HLMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.46 | 5.9% above |
| 20 week MA | $7.76 | 1.8% above |
| 50 week MA | $8.24 | 4.1% below |
| 100 week MA | $8.52 | 7.3% below |
| 200 week MA | $8.83 | 11% below |
HLMN has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
HLMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.95 | $10.2 | +2.9% |
| 2021 | $10.2 | $10.5 | +2.5% |
| 2022 | $10.5 | $6.82 | -35% |
| 2023 | $6.82 | $9.21 | +35% |
| 2024 | $9.21 | $9.80 | +6.4% |
| 2025 | $9.80 | $9.09 | -7.2% |
| 2026 YTD | $9.09 | $7.90 | -13% |
HLMN has the edge over BA on returns for 2026, with the stronger performance.